Free Trial

KDA Group (CVE:KDA) Trading Up 26.3% - Here's What Happened

KDA Group logo with Medical background

KDA Group Inc. (CVE:KDA - Get Free Report) shares traded up 26.3% on Thursday . The stock traded as high as C$0.36 and last traded at C$0.36. 557,858 shares changed hands during trading, an increase of 511% from the average session volume of 91,344 shares. The stock had previously closed at C$0.29.

KDA Group Stock Performance

The stock has a market cap of C$63.14 million, a P/E ratio of -7.50 and a beta of 1.24. The firm's 50-day moving average is C$0.26 and its two-hundred day moving average is C$0.27. The company has a quick ratio of 0.35, a current ratio of 2.10 and a debt-to-equity ratio of 7.36.

KDA Group Company Profile

(Get Free Report)

KDA Group Inc, together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.

Further Reading

Should You Invest $1,000 in KDA Group Right Now?

Before you consider KDA Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KDA Group wasn't on the list.

While KDA Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines